Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00358293
Status:
COMPLETED
Last Update Posted:
2009-01-21
First Post:
2006-07-27
Brief Title:
Study of Nighttime Dosing of Sublingual Tizanidine 12 mg in Multiple Sclerosis MS Patients With Significant Spasticity
Sponsor:
Teva GTC
Organization:
Teva GTC
Organization Data
Organization:
Teva GTC
Class:
INDUSTRY
Study ID:
Protocol C25TZ-MS-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Teva GTC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None